Personlig profil

Expertise

Fetal medicine; screening for fetal chromosomal abnormalities; preterm delivery; intrauterine growth retardation; medical education

Primære forskningsområder

Screening for fetal chromosome abnormalities in the first trimester of pregnancy, using combined first trimester risk assessment, and/or cell-free fetal DNA analysis.

Prediction of pretem delivery using assessment of cervical length.

Prevention of preterm delivery.

Long-term follow up after detection of increased nuchal translucency or structural anormalies in the first and second trimester of pregnancy.

Intrauterine growth retardation.

Physical wellbeing in pregnancy.

Aktuel forskning

Prediction of preterm delivery by cervical length assessment, in the general population and in high-risk groups.

Detection of Trisomy 21 using the current first trimester risk assessment, in comparison to cfDNA testing.

Follow-up of infants detected with ventriculomegaly at second trimester ultrasound scan.

Assessment of fetal blood flow using ultrasound and MRI.

Complications in monochorionic pregnancies.

WHO study on Intrauterine growth in normal pregnancies.

Low back pain in pregnancy: RCT on the effect of water training.

 

Mulige interessekonflikter

Ariosa-Roche have performed cfDNA tests in two studies, at cost price.

Eksterne ansættelser

Københavns Universitet

2005 → …

Fingeraftryk

Dyk ned i forskningsemnerne, hvor Ann Tabor er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
  • 1 Lignende profiler

Samarbejde og topforskningsområder i de sidste fem år

Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller